McCauliffe DP , Sontheimer RDMolecular characterization of the Ro/SS-A autoantigens. J. Invest Dermatol.1993; 100: 732-79S.
2.
Ben-Chetrit E. , Fox RI, Tan EMDissociation of immune responses to the SS-A(Ro) 52-kD and 60-kD polypeptides in systemic lupus erythematosus and Sjogren's syndrome. Arthiritis Rheum1990; 33: 349-355.
3.
Ricchiuti V. et al. Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogenous antibody profiles in human autoimmune sera. Clin Exp Immunol1994; 95: 397-407.
4.
St. Clair EW , Burch JA, Jr, Saitta M.Specificity of autoantibodies for recombinant 60-kD and 52-KD Ro autoantigens. Arthritis Rheum1994; 37: 1373-1379.
5.
Slobbe RL et al. Detection and occurrence of the 60- and 52-kD Ro (SS-A) antigens and of autoantibodies against these proteins. Clin Exp Immunol199186: 99-105.
6.
McCauliffe DP , Yin H., Wang L, LucasLAutoimmune sera react with multiple epitopes on recombinant 52 and 60 kDa Ro(SSA) proteins. J Rheumatol1994; 21: 1073-1080.
7.
McCauliffe DP et al. SimilarRo/SS-A autoantibody epitope and titer responses in annular erythema of Sjogren's syndrome and subacture cutaneous lupus erythematosus. Arch Dermatol1996; 132: 528-531.
8.
Harley JB, Reichlin M.Antibodies to Ro/SSA and La/SSB. In: Wallace DJ, Hahn BH (eds). Dubois' Lupus ErythematosusLea & Febiger, Philadelphia: 1993; pp. 225-232.
9.
Topfer F., Gordon T., McCluskey J.Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). Proc Natl Acad Sci USA1995; 92: 875-879.
10.
Manoussakis MN et al. Detection of Anti-Ro(SSA) antibodies in autoimmune diseases: Comparison of five methods. Br J Rheumatol1993; 32: 449-455.
11.
Meilof JF et al. The detection of anti-Ro/SS-A and anti-La/SS-B antibodies: A comparison of counterimmunoelectrophoresis with immunoblot, ELISA, and RNA-precipitation assays. J Immunol Methods1990; 133: 215-226.
12.
Lee LA et al. The autoantibody response to Ro/SS-A in cutaneous lupus erythematosus . Arch Dermatol1994; 130: 1262-1268.
13.
Jaskowski TD et al. Comparison of three commercially available enzyme immunoassays for the screening of autoantibodies to extractable nuclear antigens. J Clin Lab Anal1995; 9: 166-172.
14.
Provost TT et al. Detection of anti Ro(SSA) antibodies by gel double diffusion and a sandwich ELISA in systemic and subacute cutaneous lupus erythematosus and Sjorgen's syndrome. J Autoimmun1991; 4: 87-96.
15.
Reichlin M.Reichlin MMAutoantibodies to the Ro/SS-A particle react preferentially with the human antigen. J Autoimmun1989; 2: 359-365.
16.
Maddison PJ , Provost TT, Reichlin M.Serologic findings in patients with 'ANA-negative' SLE. Medicine1981; 60: 87-94.
17.
Wermuth DJ, Geoghegan WD, Jordon REAnti-Ro/SSA antibodies. Association with a particulate (large speckled-like thread) immunofluorescent nuclear staining pattern. Arch Dermatol1985 ; 121: 335-338.
18.
Clark G., Reichlin M., Tomasi TBCharacterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol1969; 102: 117-122.
19.
Maddison PJ , Mogavero M.Provost TT, Reichlin M. The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol1979; 6: 189-195.
20.
Synkowski DR , Reichlin M., Provost TTSerum autoantibodies in systemic lupus erythematosus and correlation with cutaneous features. J Rheumatol1982; 9: 380-385.
21.
Hochberg MC et al. Systemic lupus erythematosus: A review of clinico-laboratory features and immunogenetic markerjs in 150 patients with emphasis on demographic subsets. Medicine1985; 64: 285-295.
22.
Simmons-O'Brien E. et al. One hundred anti-Ro (SS-A) antibody positive patients: A 10 year follow-up. Medicine1995; 74: 109-130;
23.
Fritzler MJ , Pauls JD, Kinsella TD, Bowent J.Antinuclear, anticytoplasmic and anti-Sjogren's syndrome antigen A (SS-A/Ro) antibodies in female blood donors. Clin Immunol Immmunopathol1985; 36: 120-128.
24.
Sontheimer RDSubacute cutaneous lupus erythematosus: a decade's perspective. Med Clin North Am1989 ; 73: 1073-1090.
Sontheimer RD et al. Serologic and HLA associations in subacute cutaneous lupus erythematosus. Ann Intern Med1982; 97: 664-671.
27.
Lee GA et al. Pattern of cutaneous immunoglobulin G deposits in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro(SSA) autoantibodies into human skin-grafted mice. J Clin Invest1989; 83: 1556-1562.
Crowson AN, Magro CMDiltiazem and subacute cutaneous lupus erythematosus-like lesions. N Engl J Med1995; 333: 1429.
30.
Parodi A., Rivara G., Guarrera M.Possible naproxen-induced relapse of subacute cutaneous lupus erythematosus . JAMA1992; 268: 51-52.
31.
Miyagawa S. , Okuchi T. Shiomi Y, Sakamoto K.Subacute cutaneous lupus erythematosus lesions precipitated by griseofulvin. J Am Acad Dermatol1989; 21: 343-346.
32.
Reed BR et al. Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med1985; 103: 4951.
33.
Fine RMSubacute cutaneous lupue erythematosus associated with hydrochlorothiazide therapy. Int J Dermatol1989; 28: 375-376.
34.
Miyagawa S. , Sakamoto K.Adverse reactions to griseofulvin in patients with circulating anti-SSA/Ro and SSB/La autoantibodies. Am J Med1989; 87: 100-102.
35.
Wallace DJThe relationship between discoid and systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds). Dubois' Lupus ErythematosusLea & Febiger, Philadelphia: 1993; pp. 310-312.
36.
Callen JPSystemic lupus erythematosus in patients with chronic cutaneous (discoid) lupus erythematosus. J Am Acad Dermatol1985 ; 12: 278-288.
37.
Tappeiner G. et al. Systemic lupus erythematosus in hereditary deficiency of the fourth component of complement. J Am Acad Dermatol1982; 7: 66-79.
Nusinow SR, Zuraw BL, Curd JGThe hereditary and acquired deficiencies of complement. Med Clin North Am1985; 69: 487-504.
40.
Sturfelt G. et al . Homozygous C4A deficiency in systemic lupus erythematosus: analysis of patients from a defined population. Clin Genet1996; 38: 427-433.
41.
Cataggio LJ , Skinner RP, Smith G., Maddison PJSystemic lupus erythematosus in the elderly: Clinical and serologic characteristics. J Rheumatol1984 ; 11: 175-181.
42.
Rowell NR, Beck JS, Anderson JRLupus erythematosus and erythema multiforme-like lesions. Arch Dermatol1963 ; 88: 176-180.
43.
Alspauth M. , Maddison P.Resolution of the identify of certain antigen-antibody systems in systemic lupus erythematosus and Sjogren's syndrome: An interlaboratory collaboration. Arthritis Rheum1979; 22: 796-798.
44.
Parodi A., Drago EF, Varaldo G., Rebora A.Rowell's syndrome. JAm Acad Dermatol1989 ; 21: 374-377.
45.
Kulick KB, Mogavero H., Provost TT, Reichlin M.Serologic studies in patients with lupus cerythematosus and psoriasis. J Am Acad Dermatol1983; 8: 631-634.
46.
McGrath HJ, Scopelitis E., Nesbitt Ltj.Subacute cutaneous lupus erythematosus during psoralen ultraviolet A therapy . Arthritis Rheum1990; 33: 302-303.
47.
Mond CB, Peterson Mge, Rothfield NFCorrelation of anti-Ro antibody with phtosensitivity rash in systemic lupus erythematosus. Arthritis Rheumat1989; 32: 202-204.
48.
Sutej PJ et al. Photosensitivity and anti-Ro (SS-A) antibodies in black patients with systemic lupus erythematosus. J Rheumzatol1996; 28: 321-324.
49.
Provost TT, Ahmed AR, Maddison PJ, Reichlin M.Antibodies to cytoplasmic antigens in lupus erythematosus. Arthritis Rheum1977; 20: 1457-1463.
50.
Black AA, McCauliffe DP, Sontheimer RDPrevalence of acne rosacea in a rheumatic skin disease subspecialty clinic . Lupus1992; 1: 229-237.
51.
Boire G. et al. Rheumatoid arthritis: Anti-Ro antibodies define a none-HLA-DR4 associated clinicoserological cluster. J Rheumatol1993; 20: 1654-1660.
52.
Davis TL, Lyde CB, Davis BM, Sontheimer RDPerturbation of experimental ultraviolet light-induced erythema by passive transfer of serum from subacute cutaneous lupus erythematosus patients. J Invest Dermatol1989; 92: 573-577.
53.
Lehmann P. et al. Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol1990; 22: 181-187.
Wolska H., Blaszczyk M., Jablonska S.Photests in patients with various forms of lupus erythematosus. Int J Dermatol1989; 28: 98-103.
56.
Kiss M., Husz S., Dobozy A.The occurrence of antinuclear, anti-SSA/ Ro and anti-SSB/La antibodies in patients with polymorphous light eruption. Acta Derm Verereol1991; 71: 341-343.
57.
Murphy GM, Hawk Jlm.The prevalence of antinuclear antibodies in patients with apparent polymorphic light eruption. Br J Dermatol1991; 125: 448-451.
58.
Petzelbauer P. et al. Severe sun sensitivity and the presence of antinuclear antibodies in patients with polymorphous light eruption-like lesions. J Am Acad Dermatol1992; 26: 68-74.
59.
Epstein JHPolymorphous light eruption. JAm Acad Dermatol1980; 3: 329-343.
60.
Holzle E., Plewig G., von Kries R., Lehman P.Polymorphous light eruption. J Invest Dermatol1987 ; 88: 32S-38S.
61.
Cropley TG, Fitzpatrick TBDermatologic diagnosis by recognition of clinical morphologic patterns and syndromes. In: Fitzpatrick TB et al (eds). Dermatology in General MedicineMcGraw-Hill, Inc, New York: 1993; pp. 55-66.
62.
Kurata Y. et al. High-titer antinuclear antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura . Thromb Haemost1994; 71: 184-187.
63.
Adachi M. et al. Thrombocytopenia subsequently develops systemic lupus erythematosus—can anti-SS-A antibody predict the next event?. JapJ Med1990; 29: 481-486.
64.
Senecal JL, Chartier S., Rothfield N.Hypergammaglobulinemic purpura in systemic autoimmune rheumatic diseases: predictive value of anti-Ro(SSA) and anti-La(SSB) antibodies and treatment with indomethacin and hydroxychloroquine. J Rheumatol1995; 22: 868-875.
65.
Tsokos GC, Pillemer SR, Klippel JHRheumatic disease syndromes associated with antibodies to the Ro(SS-A) ribonuclear protein. Semin Arthritis Rheum1987; 16: 237-244.
66.
Alexander EL , Arnett FC, Provost TT, Stevens MBSjogren's syndrome: Association of anti-Ro (SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med1983; 98: 155-159.
67.
Harley JB et al. Anti-Ro (SS-A) and antiB) in patients with Sjogren's syndrome . Arthritis Rheum1986; 29: 196-206.
68.
Ruiz-Arguelles GJThe 'lipstick-on-teeth' sign in Sjogren's syndrome. N Engl J Med1986; 315: 1030-1031.
69.
Jacobsson L. et al. Association of dry eyes and dry mouth with anti-Rp/SS-A and anti-La/SS-B autoantibodies in normal adults. Arthritis Rheum1992; 35: 1492-1500.
70.
Tsuzaka K. et al. Relationship between autoantibodies and clinical parameters in Sjogren's syndrome. Rheumatol1995; 22: 1-9.
71.
Fossaluzza V., De Vita S.Clinical differences between ANA/anti-ENA positive or negative primary Sjogren's syndrome. Clin Rheumatol1992; 11: 385—387.
72.
Provost TT, Watson R.Cutaneous manifestations of Sjogren's syndrome. Rheum Dis Clin North Am1992; 18: 609-616.
73.
Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJSjogren's syndrome-A clinical, pathological and serological study of sixty-two cases. Medicine1965; 44: 187-231.
74.
Ellman P., Weber FP, Goddier Tew.A contribution to the pathology of Sjorgen's disease. Q J Med1951; 20: 33-45.
75.
Mitchell J. et al. Anhidrosis (hypohidrosis) in Sjogren's syndrome. J Am Acad Dermatol1987; 16: 233—235.
76.
Nishikawa T. , Provost TTDifferences in clinical, serologic, and immunogenetic features of white versus Oriental anti-SS-A/Ropositive patients. J Am Acad Dermatol1991; 25: 563-564.
77.
Katayama I. et al. Annular erythema-A comparative study of Sjogren Syndrome with subacute cutaneous lupus erythematosus. J Dermatol1991 ; 30: 635-639.
78.
Nishikawa T., Hoshino Y.Annular erythema in Sjogren's syndrome. In: Homma M et al (eds). Proceedings of the Fourth International Symposium Kugler Publications, New York: 1993; pp. 151-153.
79.
Lee LANeonatal lupus erythematosus. J Invest Dermatol1993; 100: 9S-13S.
80.
Kaneko F. et al. Neonatal lupus erytheratosus in Japan. J Am Acad Dermatol1992; 26: 397-403.
81.
Miyagawa S.Clinical, serological and immunogenetic features of Japanese anti-Ro/SS-A-positive patients with annular erythema. Dermatology1994; 189 (suppl): 11-13.
82.
Provost TT et al. The relationship between anti-Ro (SS-A) antibody-positive Sjorgen's syndrome and anti-Ro (SS-A) antibody-positive Lupus erythematosus. Arch Dermatol1988; 124: 63-71.
83.
Markusse HM , Schoonbrood M., Oudkerek M., Henzen-Logmans SCLeucocytoclastic vasculitis as a presenting feature of primary Sjorgren's syndrome. Clin Rheumatol1994; 13: 269-272.
84.
Alexander EL et al. Ro(SS-A) and La(SS-B) antibodies in the clinical spectrum of Sjogren's syndrome. J Rheumatol1982; 9: 239-246.
85.
Provost TT, Vasily D., Alexander E.Sjogren's syndrome. Cutaneous, immunologic, and nervous system manifestations . Nuerol Clin1987; 5: 405-426.
86.
Oddis CV et al. Vasculitis in systemic sclerosis: Association with Sjogren's syndrome and CREST syndrome variant. J Rheumatol1987; 14: 942-948.
87.
Seki T. et al. Cell-mediated immune-pancytopenia complicating primary Sjogren's syndrome. Am J Hematol1993; 43: 221-225.
88.
Garber ME, Mohr BW, Calabrese LHHenoch-Schonlein purpura associated with anti-Ro(SSA) and antiphospholipid antibody syndrome. J Rheumatol1993; 20: 1964-1966.
89.
Alexander EL , Provost TTCutaneous manifestations of primary Sjogren's syndrome: a reflection of vasculitis and association with anti-Ro(SSA) antibodies . J Invest Dermatol1983; 80: 386-391.
90.
Sugai S. et al. Hypergammaglobulinemic purpura in patients with Sjogren's syndrome: a report of nine cases and a review of the Japanese literature. JapJ Med1989; 28: 148-155.
Invemizzi F. et al. Hypergammaglobulinemic purpura of Waldenstrom . Ric Clin Lab1988; 18: 23-36.
93.
Dorner T. et al. Serologic characteristics in primary biliary cirrhosis associated with sicca syndrome. Scand J Gastoenterol1994; 29: 655-660.
94.
Chou M., Lee S., Chen T., Tsay GJSpecificity of antinuclear antibodies in primary biliary cirrhosis. Ann Rheum Dis1995; 54: 148-151.
95.
Penner E.Demonstration of immune complexes containing the ribonucleoprotein antigen Ro in primary biliary cirrhosis. Gastoenterology1986; 90: 724-727.
96.
Penner E., Reichlin M.Primary biliary cirrhosis associated with Sjogren's syndrome: Evidence for circulating and tissue-deposited Ro/anti-Ro immune complexes. Arthritis Rheum1982; 25: 1250-1253.
97.
Bennion SD, Norris DAUltraviolet light modulation of autoantigens, epidermal cytokines and adhesion molecules as contributing factors of the pathogenesis of cutaneous LE. Lupus1997; 6: 181-192.
98.
Golan TD, Elkon KB, Gharavi AE, Krueger JGEnhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet A irradiation. J Clin Invest1992; 90: 1067-1076.
99.
Niimi Y., Ioannides D., Buyon J., Bystryn JCHeterogenity in the expression of Ro and La antigens in human skin. Arthritis Rheum1995; 38: 1271-1276.
